化合物Palatrigine T24588

Product Introduction
Bioactivity


英文名: Palatrigine

描述: Palatrigine (BW-A 256C) 是一种具有血管紧张素转换酶抑制和β肾上腺素受体阻断特性的化合物。

体外活性: BW A256C reduced the maximum rate of depolarization of guinea-pig ventricle and dog Purkinje fibres in vitro (EC50, 2.2 X 10(-6) M and 1.8 X 10(-6) M, respectively).[1]

体内活性: In conscious dogs, BW A256C (1.5 mg/kg; intravenous infusion) or BW A256C (1.25-5 mg/kg;oral administration) caused dose-dependent suppression of the ventricular ectopic activity that occurred following 20-24 h of permanent coronary artery ligation.[1]

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 25 mg/mL (83.84 mM)


关键字: Palatrigine

相关产品: Zabicipril HCl | Rentiapril racemate | L-Isoleucyl-L-arginine | Garcinone B | Vicenin-1 | H-Ile-Pro-Pro-OH acetate | Tuna AI acetate | Libenzapril | Temocaprilat | Isocrenatoside

相关库: Anti-Cancer Compound Library | Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | Neuronal Signaling Compound Library | Inhibitor Library | GPCR Compound Library | Bioactive Compound Library

化合物Palatrigine T24588信息由TargetMol中国为您提供，如您想了解更多关于化合物Palatrigine T24588报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途